2019 ´ëÇÑÇ÷¾×ÇÐȸ ¼ºÀÎ ALL ¿¬±¸È¸ ½ÉÆ÷Áö¿ò : 2019-11-23±³À°ÀÏÀÚ : 2019-11-23
±³À°Àå¼Ò : ¼¿ï´ëÇб³ Ä¡°úº´¿ø ÁöÇÏ1Ãþ Á¦2°ÀÇ½Ç (³²ÃÌ°ÀǽÇ)
±³À°ÁÖÁ¦ :
2019 ´ëÇÑÇ÷¾×ÇÐȸ ¼ºÀÎ ALL ¿¬±¸È¸ ½ÉÆ÷Áö¿òÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¼ºÀÎALL¿¬±¸È¸
´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581
À̸ÞÀÏ :
hematology@kams.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 80¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 3 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-23 ³²ÃÌ°ÀÇ½Ç 10:00~10:30 Hyper-CVAD based regimens ¼ÛÀÍÂù(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 11-23 ³²ÃÌ°ÀÇ½Ç 10:30~11:00 L-asparaginase containing regimens ±è¼öÁ¤(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-23 ³²ÃÌ°ÀÇ½Ç 11:00~11:30 Discussion and research planning I : Discussion and research planning I ÃÖÀ±¼÷(¿ï»êÀÇ´ë)
±³À°½Ã°£ 11-23 ³²ÃÌ°ÀÇ½Ç 11:30~12:10 Frontline therapy and management of high-risk adult ALL in Japan Yuho Najima(Komagome Hospital(Japan))
±³À°½Ã°£ 11-23 ³²ÃÌ°ÀÇ½Ç 13:30~14:00 Optimal combinations of novel immunotherapeutic agents and conventional therapies Á¤¼ºÈÆ(Àü³²ÀÇ´ë)
±³À°½Ã°£ 11-23 ³²ÃÌ°ÀÇ½Ç 14:00~14:30 Practical updates of MRD evaluation in Korea ±è¸í½Å(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11-23 ³²ÃÌ°ÀÇ½Ç 14:30~15:00 Discussion and research planning II °í¿µÀÏ(¼¿ïÀÇ´ë)